Abiopharma

News list

Teehan Brendan 🟢 acquired 402 shares of Pacira BioSciences, Inc. (PCRX) at $10.76 Transaction Date: Dec 31, 2025 | Filing ID: 000964

Full text

News bot Jan. 6, 2026, 11:59 p.m.
🔍 Teehan Brendan (Executive)

Company: Pacira BioSciences, Inc. (PCRX)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 402
Detailed Transactions and Holdings:
- Acquired 402 shares of Common Stock at $10.763 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,402.27 | transaction_form_type: 5 | Footnotes: F1
Footnotes:
- F1: Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.